CDKN2A and melanoma: In agreement with this hypothesis, it was reported that, in the p16INK4a-deficient mouse melanoma model, the frequency of metastatic melanoma initiation by NRAS Q61R was increased more than 20-fold, compared with NRAS G12D [45].